<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36997323</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Altered Gaze Control During Emotional Face Exploration in Patients With Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>264</StartPage><EndPage>269</EndPage><MedlinePgn>264-269</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000207214</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Up to 50% of patients with amyotrophic lateral sclerosis (ALS) present with cognitive problems and behavioral dysfunctions including recognition of human faces presenting different emotions. We investigated whether impaired processing of emotional faces is associated with abnormal scan paths during visual exploration.</AbstractText><AbstractText Label="METHODS">Cognitively unimpaired patients with ALS (n = 45) and matched healthy controls (n = 37) underwent neuropsychological assessment and video-based eye tracking. Eye movements were recorded while participants visually explored faces expressing different emotions (neutral, disgusted, happy, fearful, and sad) and houses mimicking faces.</AbstractText><AbstractText Label="RESULTS">Compared with controls, patients with ALS fixated significantly longer to regions which are not relevant for emotional information when faces expressed fear (<i>p</i> = 0.007) and disgust (<i>p</i> = 0.006), whereas the eyes received less attention in faces expressing disgust (<i>p</i> = 0.041). Fixation duration in any area of interest was not significantly associated with the cognitive state or clinical symptoms of disease severity.</AbstractText><AbstractText Label="DISCUSSION">In cognitively unimpaired patients with ALS, altered gaze patterns while visually exploring faces expressing different emotions might derive from impaired top-down attentional control with possible involvement of subliminal frontotemporal areas. This may account for indistinctness in emotion recognition reported in previous studies because nonsalient features retrieve more attention compared with salient areas. Current findings may indicate distinct emotion processing dysfunction of ALS pathology, which may be different from, for example, executive dysfunction.</AbstractText><CopyrightInformation>&#xa9; 2023 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nanning</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (F.N., K.B., I.U., A.C.L., D.L.), University of Ulm; German Center for Neurodegenerative Diseases (DZNE) (A.C.L.), Ulm; and Institute of Medical Technology (M.G.), Brandenburg University of Technology, Cottbus-Senftenberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braune</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (F.N., K.B., I.U., A.C.L., D.L.), University of Ulm; German Center for Neurodegenerative Diseases (DZNE) (A.C.L.), Ulm; and Institute of Medical Technology (M.G.), Brandenburg University of Technology, Cottbus-Senftenberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uttner</LastName><ForeName>Ingo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (F.N., K.B., I.U., A.C.L., D.L.), University of Ulm; German Center for Neurodegenerative Diseases (DZNE) (A.C.L.), Ulm; and Institute of Medical Technology (M.G.), Brandenburg University of Technology, Cottbus-Senftenberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert Christian</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (F.N., K.B., I.U., A.C.L., D.L.), University of Ulm; German Center for Neurodegenerative Diseases (DZNE) (A.C.L.), Ulm; and Institute of Medical Technology (M.G.), Brandenburg University of Technology, Cottbus-Senftenberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorges</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (F.N., K.B., I.U., A.C.L., D.L.), University of Ulm; German Center for Neurodegenerative Diseases (DZNE) (A.C.L.), Ulm; and Institute of Medical Technology (M.G.), Brandenburg University of Technology, Cottbus-Senftenberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lul&#xe9;</LastName><ForeName>Doroth&#xe9;e</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Department of Neurology (F.N., K.B., I.U., A.C.L., D.L.), University of Ulm; German Center for Neurodegenerative Diseases (DZNE) (A.C.L.), Ulm; and Institute of Medical Technology (M.G.), Brandenburg University of Technology, Cottbus-Senftenberg, Germany. dorothee.lule@uni-ulm.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021641" MajorTopicYN="N">Recognition, Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005123" MajorTopicYN="N">Eye</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005133" MajorTopicYN="N">Eye Movements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005149" MajorTopicYN="N">Facial Expression</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>21</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36997323</ArticleId><ArticleId IdType="pmc">PMC10424840</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000207214</ArticleId><ArticleId IdType="pii">WNL.0000000000207214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Papps B, Abrahams S, Wicks P, Leigh PN, Goldstein LH. Changes in memory for emotional material in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2005;43(8):1107-1114.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817168</ArticleId></ArticleIdList></Reference><Reference><Citation>Aho-&#xd6;zhan HEA, Keller J, Heimrath J, et al. . Perception of emotional facial expressions in amyotrophic lateral sclerosis (ALS) at behavioural and brain metabolic level. PLoS One. 2016;11(10):e0164655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065224</ArticleId><ArticleId IdType="pubmed">27741285</ArticleId></ArticleIdList></Reference><Reference><Citation>Girardi A, MacPherson SE, Abrahams S. Deficits in emotional and social cognition in amyotrophic lateral sclerosis. Neuropsychology. 2011;25(1):53-65.</Citation><ArticleIdList><ArticleId IdType="pubmed">20919762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman EK, Eslinger PJ, Simmons Z, Barrett AM. Emotional perception deficits in amyotrophic lateral sclerosis. Cogn Behav Neurol. 2007;20(2):79-82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1905862</ArticleId><ArticleId IdType="pubmed">17558250</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaghy C, Thurtell MJ, Pioro EP, Gibson JM, Leigh RJ. Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. J Neurol Neurosurg Psychiatry. 2011;82(1):110-116.</Citation><ArticleIdList><ArticleId IdType="pubmed">21097546</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M, M&#xfc;ller H, Lul&#xe9; D, et al. . Eye movement deficits are consistent with a staging model of pTDP-43 pathology in amyotrophic lateral sclerosis. PLoS One. 2015;10(11):e0142546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641606</ArticleId><ArticleId IdType="pubmed">26559944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. . A revision of the El Escorial criteria: 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):291-292.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1-2):9-14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Loose M, Burkhardt C, Aho-&#xd6;zhan H, et al. . Age and education-matched cut-off scores for the revised German/Swiss-German version of ECAS. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5-6):374-376.</Citation><ArticleIdList><ArticleId IdType="pubmed">27027323</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto D, Ekman P. Japanese and Caucasian Facial Expressions of Emotion (IACFEE) [Slides]. Intercultural and Emotion Research Laboratory, Department of Psychology, San Francisco State University; 1988.</Citation></Reference><Reference><Citation>Yovel G, Kanwisher N. Face perception: domain specific, not process specific. Neuron. 2004;44(5):889-898.</Citation><ArticleIdList><ArticleId IdType="pubmed">15572118</ArticleId></ArticleIdList></Reference><Reference><Citation>Noudoost B, Chang MH, Steinmetz NA, Moore T. Top-down control of visual attention. Curr Opin Neurobiol. 2010;20(2):183-190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2901796</ArticleId><ArticleId IdType="pubmed">20303256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf C, Lappe M. Top-down control of saccades requires inhibition of suddenly appearing stimuli. Atten Percept Psychophys. 2020;82(8):3863-3877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7593282</ArticleId><ArticleId IdType="pubmed">32803547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekman P, Friesen WV. Unmasking the Face: A Guide to Recognizing Emotions from Facial Clues. Prentice-Hall; 1975.</Citation></Reference><Reference><Citation>Lul&#xe9; D, Michels S, Finsel J, et al. . Clinicoanatomical substrates of selfish behaviour in amyotrophic lateral sclerosis: an observational cohort study. Cortex. 2022;146:261-270.</Citation><ArticleIdList><ArticleId IdType="pubmed">34923303</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>